Skip to content. | Skip to navigation

News
>
Presentation I December 3, 2014: Leveraging a CDMO Relationship to Expedite Time to Clinic: Success Factors for Partnering with a CDMO

Presentation I December 3, 2014: Leveraging a CDMO Relationship to Expedite Time to Clinic: Success Factors for Partnering with a CDMO

What is required to create a successful partnership with a CDMO? How does a drug developer begin the process of creating this relationship and what is involved? How are decision-making processes affected in the early development period? The 2014 PDA Europe Conference on Outsourcing/Contract Manufacturing offers insight into these questions and more.

In today’s complex drug development and manufacturing environment, many drug development companies lack the resources and expertise required to successfully bring a compound to the marketplace. Thus, a partnership with a CDMO can be of vital support in helping them to manage processes and facilitate decision-making during the early development period. But how do companies contemplating such an arrangement make the right decision when choosing a CDMO? What are the main criteria necessary to create a successful and lasting relationship? What are the success factors that make for a successful cooperation and a successful clinical trial project? On December 3, Dr. David Brett, Product and Service Manager Vetter, will offer his insights into these issues and through two case histories, illustrate how the challenges of creating the relationship were met and the lessons learned.

Presentation
December 3, 2014, 9.00 am – Hilton Hotel Berlin

Leveraging a CDMO Relationship to Expedite Time to Clinic: Success Factors for Partnering with a CDMO
2014 PDA Europe Conference on Outsourcing/Contract Manufacturing

Back to newsroom